by Internet Medical Society

Thiotepa 100 mg: A Promising Therapy for Variety of Malignancies

Thiotepa 100 mg is recommended in the palliation of several neoplastic diseases. It is effective when treating adenocarcinoma of the ovary, adenocarcinoma of the breast, papillary thyroid, and bladder cancer. The thiotepa 100 mg is used in order to control intracavitary effusions caused by the serosal neoplastic deposits. It is used as a conditioning treatment prior to hematopoietic stem cell transplantation. Thiotepa is derived as an alkylating agent which is for intravenous, intracavitary, or intravesical use.

Views: 2

Reply to This


Interested in advertising on





Submit your manuscript

© 2022   Created by Network Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service